Core Laboratories (CLB) PT Set at $116.00 by Citigroup

Citigroup set a $116.00 target price on Core Laboratories (NYSE:CLB) in a research note released on Friday morning. The brokerage currently has a hold rating on the oil and gas company’s stock.

Several other analysts have also issued reports on CLB. JPMorgan Chase & Co. reduced their price objective on shares of Core Laboratories from $121.00 to $118.00 and set an overweight rating on the stock in a report on Friday, July 27th. ABN Amro lowered shares of Core Laboratories from a hold rating to a sell rating in a report on Monday, July 2nd. Stifel Nicolaus started coverage on shares of Core Laboratories in a report on Monday, September 10th. They issued a hold rating and a $117.00 price objective on the stock. Piper Jaffray Companies restated a hold rating and issued a $96.00 price objective on shares of Core Laboratories in a report on Friday, July 27th. Finally, ValuEngine upgraded shares of Core Laboratories from a hold rating to a buy rating in a report on Tuesday, September 4th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and six have assigned a buy rating to the company. Core Laboratories has a consensus rating of Hold and a consensus price target of $115.00.

Shares of CLB stock opened at $108.91 on Friday. The company has a debt-to-equity ratio of 1.53, a quick ratio of 1.85 and a current ratio of 2.24. The stock has a market cap of $4.90 billion, a PE ratio of 54.46, a PEG ratio of 3.79 and a beta of 1.50. Core Laboratories has a twelve month low of $87.66 and a twelve month high of $130.34.

Core Laboratories (NYSE:CLB) last announced its quarterly earnings results on Wednesday, July 25th. The oil and gas company reported $0.59 earnings per share for the quarter, meeting the consensus estimate of $0.59. The firm had revenue of $175.48 million for the quarter, compared to analysts’ expectations of $174.47 million. Core Laboratories had a net margin of 13.32% and a return on equity of 64.13%. The company’s revenue was up 10.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.51 EPS. analysts forecast that Core Laboratories will post 2.44 earnings per share for the current year.

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Fisher Asset Management LLC purchased a new stake in Core Laboratories during the first quarter worth about $47,402,000. WCM Investment Management CA increased its stake in Core Laboratories by 5.1% during the first quarter. WCM Investment Management CA now owns 5,035,827 shares of the oil and gas company’s stock worth $544,977,000 after purchasing an additional 242,096 shares during the period. Millennium Management LLC increased its stake in Core Laboratories by 9,329.6% during the second quarter. Millennium Management LLC now owns 226,594 shares of the oil and gas company’s stock worth $28,598,000 after purchasing an additional 224,191 shares during the period. Sei Investments Co. increased its stake in Core Laboratories by 40.1% during the first quarter. Sei Investments Co. now owns 638,723 shares of the oil and gas company’s stock worth $69,123,000 after purchasing an additional 182,848 shares during the period. Finally, Arosa Capital Management LP purchased a new stake in Core Laboratories during the first quarter worth about $19,074,000.

Core Laboratories Company Profile

Core Laboratories N.V. provides reservoir description, and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs.

Read More: Trading Strategy Examples and Plans

Analyst Recommendations for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply